Gareth Wynn (@MelbourneEPdoc) header
Gareth Wynn (@MelbourneEPdoc) profile picture

Husband. Dad. EP. Extractor. Implanter. Ass Prof 😯 49 post-nominals: anyone have a spare one to even it up? Royal Melbourne Hospital. šŸ‡¬šŸ‡§ in šŸ‡¦šŸ‡ŗ. Quite ranty

Melbourne, Victoria
Joined August 2018
Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)Photo by Gareth Wynn (@MelbourneEPdoc)
Gareth Wynn retweeted
Supraventricular Arrhythmia Prematurity, and Risk of Incident Atrial Fibrillation #OpenAccess heartrhythmjournal.com/artic…
13
32
2,594
Gareth Wynn retweeted
Safety of Catheter Ablation compared with Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomised Trials #OpenAccess @MelbourneEPdoc @DrJasonAndrade @drjohnm @epfellow heartrhythmjournal.com/artic…
18
1
37
6,354
Z-E-R-O % !!!🫤
2
12
2
37
13,013
Gareth Wynn retweeted
At @JAMA_current today, 2 radiologists publish what should be the consent form for a total body MRI in healthy people Note: "no major medical society recommends whole-body MRI screening in the general population because it is unproven, and the harms likely outweigh the benefits." jamanetwork.com/journals/jam…
48
253
31
938
159,240
More than 10 years ago Oussama and I started our journey of investigation, trying to the define the optimal first treatment for patients with atrial fibrillation.Ā  Separately we pursed randomised studies in populations with treatment-naive paroxysmal AF.Ā  Five years ago we presented our RCTs in the paroxysmal AF population, which ended up sitting side by side in the same issue of the New England Journal of Medicine.Ā  nejm.org/doi/full/10.1056/NE… nejm.org/doi/full/10.1056/NE… Since then we have been working together to examine the same question of optimal initial therapy, but instead looking at patients with more advanced forms of atrial fibrillation.Ā  Today Oussama presented the results of the AVANT-GUARD study, which definitively demonstrated the value of initial catheter ablation in the treatment naive persistent AF population. Like EARLY-AF, AVAT GUARD used implantable cardiac monitors to evaluate arrhythmia endpoints Ā  Like EARLY-AF - initial catheter ablation reduced recurrences in AVANT GUARD by about 50%, which was about 25% in absolute terms. To put this another way, only 4 patients need to be treated with ablation to prevent a recurrence of arrhythmia.Ā  However, binary recurrence doesn’t tell the whole story. Because we had loop recorders we were able to assess the time spent in AF (or AF burden). In this regard significantly more patients had none or negligible burden after ablation (<0.1%), with significantly more AAD treated patients having a very high burden (>5%).Ā This is important as AF burden is associated with clinical outcomes such as hospitalisation. In terms of risk - the rates of any adverse event or serious adverse event were comparable between randomised arms. Highlighting that persistent AF patients with high CHADS-VASc score are high risk irrespective of treatment provided. This is important as we reflect on treatment options as part of shared decision-making. Congratulations to Oussama for the presentation and leadership, to the co-investigators and study sites for their participation and dedication, and a huge thank you to the Boston Scientific team for their support and commitment to advancing science.Ā  To end, I want to acknowledge and thank Oussama for this shared journey, I’m grateful for our collaboration and friendship, and look forward to what we will do next.
Presented at #HRS2026: In patients with persistent atrial fibrillation, first-line treatment with pulsed field ablation reduced the recurrence of atrial arrhythmias at 12 months as compared with antiarrhythmic drugs. Full AVANT GUARD trial results: nejm.org/doi/full/10.1056/NE… @HRSonline
3
51
1
172
29,286
Hot off the press 2026 @HRSonline #CIED management guidelines just dropped - and these ones have a real pulse! Honored to contribute and represent @IDSAInfo @bcmhouston @BCMCME heartrhythmjournal.com/artic…
2
7
16
1,636
FlecaED: safety & efficacy of IV FLEC in selected AF pts with stable CAD EF > 35% in RCT vs Amio #EHRA2026
14
1
46
10,737
Gareth Wynn retweeted
Safety of Catheter Ablation compared with Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomised Trials #OpenAccess @MelbourneEPdoc @DrJasonAndrade @drjohnm @epfellow heartrhythmjournal.com/artic…
1
16
38
3,778
Gareth Wynn retweeted
Register now for free: talesymposium.com #EPeeps
9
1
29
3,498
Gareth Wynn retweeted
Spanish Prime Minister Pedro SƔnchez on Iran: Today more than ever, it is essential to remember that one can be against a hateful regime, as is the case with the Iranian regime, as is the whole of Spanish society, and at the same time be against an unjustified, dangerous military intervention outside of international law. That one must be against a war initiated without the authorization of the United States Congress or the United Nations Security Council and, as I have said before, one that violates international law. And that there is always room for a negotiated solution, instead of being dragged along by the devastation of arms as the only possible way out. Therefore, I would like once again, as we have done since the beginning, to appeal for immediate de-escalation, for full respect for international law in all the conflicts we are unfortunately suffering, and for the urgency of resuming dialogue as soon as possible. That is where Spain will be, and that is where I believe the whole of the European Union should be.
475
2,918
432
10,607
2,249,531
Here we describe a novel approach to vascular conduit creation to enable CIED implantation in a 4-patient series with limited venous access. A useful technique to explore in those with limited vascular access. @Dr_JHAnderson @JACCJournals @MayoClinic jacc.org/doi/10.1016/j.jacep…
1
7
10
1,246
Outcome of Pentaspline PFA outside PVs šŸ‘‡ Acute success does not necessarily translate into long-term success.
4
15
3
48
9,399
In light of the recently published ALONE-AF trial, which tested the hypothesis that OAC discontinuation post ablation was a safe(r) strategy for patients I thought it would be good to review our recently larger meta-analysis on the topic. In this analysis we examined 63 RCTs containing 11,161 patients We found catheter ablation: 🧠 Reduced the risk of stroke by 37% (7 less stroke per 1000 treated patients) ā˜ ļø Reduced the risk of death by 23% (16 less deaths per 1000 treated patients) In conclusion, this large analysis of multiple RCTs shows that ablation reduces hard cardiovascular outcomes with high certainty. Thus providing rationale for why OAC may not be necessary post ablation, as the risk of stroke is substantially reduced (eg 1.5% in OPTION, and 0.3-0.8% in ALONE-AF) acpjournals.org/doi/10.7326/… @DilawriCVI @UBC @UBCCardio @drjohnm
12
29
1
74
8,800
The AQUATIC trial may be the most definitive trial of #ESCCOngress The common combo of ASA and OAC for pts with CAD/stent and AF is clearly been harming people. Lots. MACE worse, Death worse, Bleeding way worse. STOP THE ASA when on OAC nejm.org/doi/full/10.1056/NE…
10
129
4
391
39,038
High Incidence of Phrenic Nerve Injury in Patients Undergoing Pulsed Field Ablation for Atrial Fibrillation #OpenAccess heartrhythmjournal.com/artic…
2
25
2
84
30,025
Mirror mirror in the leads, is there insulation breach? heartrhythmcasereports.com/a…
2
16
1
42
6,096
Two amazing days at this year’s CIED implanter’s Masterclass @AnzRhythm
2
3
227
The AMA Victoria team has been out at the @Austin_Health clinical school today with our friends from @DocsEnvAus to support an important interdisciplinary workshop on sustainable healthcare, attended by final year students from @UniMelb.
2
2
301
Gareth Wynn retweeted
The latest video in our partnership with @DGlaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free: nej.md/DrG16
4
66
3
348
50,365